Morpheus8 is a safe and effective minimally invasive modular RF fractional solution for sub-dermal adipose remodeling. The Morpheus 8 procedure can be especially effective for improving the texture and tone of the skin, reducing skin laxity, and smoothing out creases and lines.

KEY BENEFITS: For facial soft tissue and small hard-to-reach treatment areas. Delivers fractional resurfacing and sub-dermal treatments, penetrating tissue up to 5mm (4mm + 1mm thermal profile) to stimulate collagen production. Clinically proven to remodel sub-dermal and dermal tissue through fractional coagulation of fat and bulk sub-necrotic heating.

Three interchangeable fractional tips with different microneedle configurations: 12 pin Mopheus8 Prime for small narrow areas such as the periorbital zone and upper lip 24 pin Morpheus8 for larger facial areas such as the forehead, nasolabial folds, jawlines, and neck 24 pin Morpheus8 Resurfacing for the treatment of superficial conditions, including scarring Safe on skin types up to and including VI with little risk of post inflammatory hyperpigmentation (PIH) which is common with other resurfacing methods.

Contraindications: • Pacemaker or internal defibrillator. (For RF applications only) • Superficial implants, such as metal plates, screws and metal piercing • The hand piece should be used at least 1cm away from cochlear implants in the ear. (For RF applications only) • Silicone implants or an injected chemical substance, unless deep enough in the periosteal plane in the treatment area (For RF applications only). • Any surgery in the treatment area performed within a year prior to treatment. • Having received treatment with light, laser, RF, or other devices in the treated area within 2-3 weeks for non-ablative procedures, and 6-12 weeks for ablative fractional laser resurfacing (according to treatment severity) prior to treatment, except special recommendations. • Treating over tattoo or permanent makeup. • Treating over the lips. • Treating over eyebrows or other hair bearing surfaces. • Any facial surgery performed within a year prior to treatment. • Current or history of skin cancer, or current condition of any other type of cancer, or pre- malignant moles. • Intra-dermal or superficial sub-dermal areas injected with Botox®/HA/collagen/fat injections or other augmentation methods with bio-material, before the product has been dissipated (up to 6 months), except Botox after binding to the facial muscles (3-7 days). It is possible to treat sooner over injectable products placed in the deep, periosteal plane as soon as the area has healed (1-3 weeks). • Severe concurrent conditions, such as cardiac disorders, sensory disturbances, uncontrolled hypertension, and liver or kidney diseases. • Pregnancy and nursing. • Diseases which may be stimulated by light at the wavelengths used, such as history of Systemic Lupus Erythematosus, Porphyria, and Epilepsy (for optical applications only). • Impaired immune system due to immunosuppressive diseases such as AIDS and HIV or use of immunosuppressive medications. • Isotretinoin (Accutane) within last 6 months. • Poorly controlled endocrine disorders, such as diabetes, thyroid dysfunction, and hormonal virilization such as polycystic ovary syndrome. • Any surgical procedure in the treatment area within the last three months or before complete healing. • Facial laser resurfacing, facial dermabrasion, and deep chemical peeling within the last three months if face is being treated. • Vitiligo • Treating over tattoo or permanent makeup. • As per the practitioner's discretion, refrain from treating any condition which might make it unsafe for the patient. • Excessively tanned skin from sun, tanning beds or tanning creams and sprays within the last two weeks.